Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes

Health and Quality of Life Outcomes

Volumn 5, Issue , 2007, Pages

  Snoek, Frank J ^a   Skovlund, Søren E ^b   Pouwer, Frans ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONCURRENT VALIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; DIET THERAPY; DISCRIMINANT VALIDITY; FACTORIAL ANALYSIS; FEMALE; HUMAN; INSULIN PUMP; INSULIN TREATMENT APPRAISAL SCALE; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROBLEM AREAS IN DIABETES SCALE; PSYCHOMETRY; RATING SCALE; RELIABILITY; SELF CONCEPT; WORLD HEALTH ORGANIZATION FIVE ITEM WELL BEING INDEX; DRUG EFFECT; DRUG MONITORING; INSTRUMENTATION; MIDDLE AGED; PATHOPHYSIOLOGY; PERCEPTION; SICKNESS IMPACT PROFILE; UNITED STATES; VALIDATION STUDY;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PERCEPTION; PSYCHOMETRICS; SELF CONCEPT; SICKNESS IMPACT PROFILE; UNITED STATES;

EID: 39349104333     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-5-69     Document Type: Article

References (21)

1. Turner RC Cull CA Frighi V Holman RR UK Prospective Diabetes Study (UKPDS) group. Glycemic control with diet, sulphonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS49) JAMA 2012, 281:2005-1999. 10.1001/jama.281.21.2005
2. Chan JL Abrahamson MJ Pharmacological management of type 2 diabetes mellitus: Rationale for rational use of insulin Mayo Clin Proc 2003, 78:459-467. 12683698
3. Wallace TM Matthews DR Poor glycaemic control in type 2 diabetes: A conspiracy of disease, suboptimal therapy and attitude Q J Med 2000, 93:369-374.
4. Korytkoski M When oral agents fail: Practical barriers to starting insulin Int J Obes Relat Metab Disord 2002, 26:S18-S24. 10.1038/ sj.ijo.0802173
5. Leslie CA Satin-Rapaport W Matheson D Stone R Enfield G Psychological insulin resistance: A missed diagnosis? Diabetes Spectrum 1994, 7(1):52-57.
6. Hunt LM Valenzuela MA Pugh JA NIDDM patients' fears and hopes about insulin therapy: The basis for patient reluctance Diabetes Care 1997, 20:291-298. 10.2337/diacare.20.3.292
7. Peyrot M Rubin R Lauritzen T Skovlund SE Snoek FJ Matthews DR Landgraf R Kleinebreil L Resistance to insulin therapy among patients and providers. Results of the cross-national Attitudes, Wishes and Needs (DAWN) study Diabetes Care 2005, 28:2673-2679. 10.2337/ diacare.28.11.2673 16249538
8. Polonsky WH Psychological insulin resistance in patients with type 2 diabetes. The scope of the problem Diabetes Care 2005, 28:2543-2545. 10.2337/diacare.28.10.2543 16186296
9. Meece J Dispelling myths and removing barriers about insulin in type 2 diabetes Diabetes Educator 2006, 32(1):9S-18S. 10.1177/0145721705285638 16439485
10. Brod M Skovlund SE Wittrup-Jensen KU Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience Qual Life Res 2006, 15:481-491. 10.1007/ s11136-005-1624-6 16547787
11. Polonsky WH Anderson BJ Lohrer PA Welch GW Jacobson AM Aponte JE Schwartz CE Assessment of diabetes-related distress Diabetes Care 1995, 18:754-760. 10.2337/diacare.18.6.754 7555499
12. Snoek FJ Pouwer F Welch GW Polonsky WH Diabetes-related emotional distress in Dutch and US Diabetic Patients. Cross-cultural validity of the Problem Areas In Diabetes scale Diabetes Care 2000, 23:1305-1309. 10.2337/diacare.23.9.1305 10977023
13. Welch GW Weinger K Anderson B Polonsky WH Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire Diabet Med 2003, 20:69-72. 10.1046/j.1464-5491.2003.00832.x 12519323
14. Bech P Olsen LR Kjoler M Rasmussen NK Measuring well-being rather than the absence of distress symptoms: A comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale Int J Methods Psychiatr Res 2003, 12:385-401. 10.1002/mpr.145
15. Awata S Bech P Yoshida S Hirai M Suzuki S Yamashita M Ohara A Hinokio Y Matsuoka H Oka Y Reliability and validity of the Japanese version of the World Health Organization-Five Well-being Index in the context of detecting depression in diabetic patients Psychiatr Clin Neurosc 2007, 61:112-119. 10.1111/j.1440-1819.2007.01619.x
16. Lowe B Spitzer RL Grafe K Kroenke K Quenter A Zipfel S Bucholz C Witte S Herzog W Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physician's diagnosis J Affective Disord 2004, 78:131-140. 10.1016/S0165-0327(02)00237-9
17. Vet de HC Ader HJ Terweee CB Pouwer F Are factor analytical techniques used appropriately in the validation of health status questionnaires. A systematic review on the quality of factor analysis of the SF-36 Qual Life Res 2005, 14:1203-18. 10.1007/s11136-004-5742-3 16047498
18. Pouwer F Makine C Karsidag Ç Kadioglu P Karsidag K Skovlund SE Snoek FJ Negative appraisal of insulin therapy and depression in insulin-naïve patients with type 2 diabetes Diabetes 2007, A504:1992-P.
19. Anderson RJ Freedland KE Clouse RE Lustman PJ The prevalence of co-morbid depression in adults with diabetes Diabetes Care 2001, 6:1069-1078. 10.2337/diacare.24.6.1069
20. Ciechanowski PS Katon WJ Russo JE Depression and diabetes: Impact of depressive symptoms on adherence, function and costs Arch Int Med 2000, 160:3278-3285. 10.1001/archinte.160.21.3278
21. Triplitt CL New technologies and therapies in the management of diabetes Am J Manag Care 2007, 13:lS47-S54.